ImmuCell Corporation Share-based Payment Arrangement, Expense
ImmuCell Corporation (ICCC) reported Share-based Payment Arrangement, Expense of $239.87 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-13
- ImmuCell Corporation share-based payment arrangement, expense for the quarter ending 2026-06-30 was $239.87K, a 259.55% increase year-over-year.
- ImmuCell Corporation share-based payment arrangement, expense for the quarter ending 2026-03-31 was $137.95K, a 164.19% increase year-over-year.
- ImmuCell Corporation share-based payment arrangement, expense for the quarter ending 2025-12-31 was $103.78K, a 50.71% increase year-over-year.
- ImmuCell Corporation share-based payment arrangement, expense for the quarter ending 2025-09-30 was $73.16K, a 5.67% decline year-over-year.
- ImmuCell Corporation share-based payment arrangement, expense for fiscal 2025 was $295.87K, a 9.12% decline from fiscal 2024.
- ImmuCell Corporation share-based payment arrangement, expense for fiscal 2024 was $325.55K, a 11.74% decline from fiscal 2023.
- ImmuCell Corporation share-based payment arrangement, expense for fiscal 2023 was $368.87K, a 38.54% increase from fiscal 2022.
- ImmuCell Corporation share-based payment arrangement, expense for fiscal 2022 was $266.24K, a 84.49% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $239.87K 10-Q · filed 2026-08-13 | $377.82K 10-Q · filed 2026-08-13 | $481.60K derived: sum of 3 quarters · filed 2026-08-13 | $554.76K derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $137.95K 10-Q · filed 2026-05-14 | $241.73K derived: sum of 2 quarters · filed 2026-05-14 | $314.89K derived: sum of 3 quarters · filed 2026-05-14 | $381.61K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $103.78K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $176.94K derived: sum of 2 quarters · filed 2026-03-30 | $243.66K derived: sum of 3 quarters · filed 2026-08-13 | $295.87K 10-K · filed 2026-03-30 |
| 2025-09-30 | $73.16K 10-Q · filed 2025-11-13 | $139.88K derived: sum of 2 quarters · filed 2026-08-13 | $192.09K 10-Q · filed 2025-11-13 | $260.95K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $66.71K 10-Q · filed 2026-08-13 | $118.93K 10-Q · filed 2026-08-13 | $187.79K derived: sum of 3 quarters · filed 2026-08-13 | $265.35K derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $52.22K 10-Q · filed 2026-05-14 | $121.08K derived: sum of 2 quarters · filed 2026-05-14 | $198.63K derived: sum of 3 quarters · filed 2026-05-14 | $296.66K derived: sum of 4 quarters · filed 2026-05-14 |
| 2024-12-31 | $68.86K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $146.42K derived: sum of 2 quarters · filed 2026-03-30 | $244.44K derived: sum of 3 quarters · filed 2026-03-30 | $325.55K 10-K · filed 2026-03-30 |
| 2024-09-30 | $77.56K 10-Q · filed 2025-11-13 | $175.58K derived: sum of 2 quarters · filed 2025-11-13 | $256.69K 10-Q · filed 2025-11-13 | $357.35K derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $98.02K 10-Q · filed 2025-08-14 | $179.13K 10-Q · filed 2025-08-14 | $279.79K derived: sum of 3 quarters · filed 2025-08-14 | $376.22K derived: sum of 4 quarters · filed 2025-08-14 |
| 2024-03-31 | $81.11K 10-Q · filed 2025-05-14 | $181.77K derived: sum of 2 quarters · filed 2025-05-14 | $278.20K derived: sum of 3 quarters · filed 2025-05-14 | $353.86K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $100.66K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $197.09K derived: sum of 2 quarters · filed 2025-03-28 | $272.75K derived: sum of 3 quarters · filed 2025-03-28 | $368.87K 10-K · filed 2025-03-28 |
| 2023-09-30 | $96.43K 10-Q · filed 2024-11-13 | $172.09K derived: sum of 2 quarters · filed 2024-11-13 | $268.21K 10-Q · filed 2024-11-13 | $333.60K derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $75.66K 10-Q · filed 2024-08-13 | $171.77K 10-Q · filed 2024-08-13 | $237.17K derived: sum of 3 quarters · filed 2024-08-13 | $322.29K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | $96.12K 10-Q · filed 2024-05-14 | $161.51K derived: sum of 2 quarters · filed 2024-05-14 | $246.63K derived: sum of 3 quarters · filed 2024-05-14 | $308.27K derived: sum of 4 quarters · filed 2024-05-14 |
| 2022-12-31 | $65.39K derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $150.52K derived: sum of 2 quarters · filed 2024-04-01 | $212.15K derived: sum of 3 quarters · filed 2024-04-01 | $266.24K 10-K · filed 2024-04-01 |
| 2022-09-30 | $85.12K 10-Q · filed 2023-11-13 | $146.76K derived: sum of 2 quarters · filed 2023-11-13 | $200.85K 10-Q · filed 2023-11-13 | $241.78K derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $61.63K 10-Q · filed 2023-08-10 | $115.73K 10-Q · filed 2023-08-10 | $156.66K derived: sum of 3 quarters · filed 2023-08-10 | $202.15K derived: sum of 4 quarters · filed 2023-08-10 |
| 2022-03-31 | $54.09K 10-Q · filed 2023-05-11 | $95.02K derived: sum of 2 quarters · filed 2023-05-11 | $140.51K derived: sum of 3 quarters · filed 2023-05-11 | $163.78K derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | $40.93K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $86.42K derived: sum of 2 quarters · filed 2023-03-29 | $109.68K derived: sum of 3 quarters · filed 2023-03-29 | $144.31K 10-K · filed 2023-03-29 |
| 2021-09-30 | $45.49K 10-Q · filed 2022-11-21 | $68.75K derived: sum of 2 quarters · filed 2022-11-21 | $103.38K 10-Q · filed 2022-11-21 | $160.08K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-06-30 | $23.27K 10-Q/A · filed 2022-11-21 | $57.89K 10-Q/A · filed 2022-11-21 | $114.59K derived: sum of 3 quarters · filed 2022-11-21 | $176.99K derived: sum of 4 quarters · filed 2022-11-21 |
| 2021-03-31 | $34.63K 10-Q/A · filed 2022-11-21 | $91.33K derived: sum of 2 quarters · filed 2022-11-21 | $153.73K derived: sum of 3 quarters · filed 2022-11-21 | $210.36K derived: sum of 4 quarters · filed 2022-11-21 |
| 2020-12-31 | $56.70K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $119.10K derived: sum of 2 quarters · filed 2022-03-30 | $175.73K derived: sum of 3 quarters · filed 2022-03-30 | $253.13K 10-K · filed 2022-03-30 |
| 2020-09-30 | $62.40K 10-Q · filed 2021-11-15 | $119.03K derived: sum of 2 quarters · filed 2021-11-15 | $196.44K 10-Q · filed 2021-11-15 | $288.01K derived: sum of 4 quarters · filed 2021-11-15 |
| 2020-06-30 | $56.63K 10-Q · filed 2021-08-12 | $134.04K 10-Q · filed 2021-08-12 | $225.61K derived: sum of 3 quarters · filed 2021-08-12 | $294.27K derived: sum of 4 quarters · filed 2021-08-12 |
| 2020-03-31 | $77.40K 10-Q · filed 2021-05-13 | $168.98K derived: sum of 2 quarters · filed 2021-05-13 | $237.63K derived: sum of 3 quarters · filed 2021-05-13 | $307.71K derived: sum of 4 quarters · filed 2021-05-13 |
| 2019-12-31 | $91.58K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $160.23K derived: sum of 2 quarters · filed 2021-03-30 | $230.31K derived: sum of 3 quarters · filed 2021-03-30 | $313.14K 10-K · filed 2021-03-30 |
| 2019-09-30 | $68.65K 10-Q · filed 2020-11-12 | $138.73K derived: sum of 2 quarters · filed 2020-11-12 | $221.57K 10-Q · filed 2020-11-12 | $307.89K derived: sum of 4 quarters · filed 2020-11-12 |
| 2019-06-30 | $70.08K 10-Q · filed 2020-08-12 | $152.92K 10-Q · filed 2020-08-12 | $239.24K derived: sum of 3 quarters · filed 2020-08-12 | $328.94K derived: sum of 4 quarters · filed 2020-08-12 |
| 2019-03-31 | $82.83K 10-Q · filed 2020-05-13 | $169.15K derived: sum of 2 quarters · filed 2020-05-13 | $258.86K derived: sum of 3 quarters · filed 2020-05-13 | $355.80K derived: sum of 4 quarters · filed 2020-05-13 |
| 2018-12-31 | $86.32K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-27 | $176.03K derived: sum of 2 quarters · filed 2020-03-27 | $272.97K derived: sum of 3 quarters · filed 2020-03-27 | $344.02K 10-K · filed 2020-03-27 |
| 2018-09-30 | $89.71K 10-Q · filed 2019-11-12 | $186.65K derived: sum of 2 quarters · filed 2019-11-12 | $257.70K 10-Q · filed 2019-11-12 | $309.44K derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $96.94K 10-Q · filed 2019-08-12 | $167.99K 10-Q · filed 2019-08-12 | $219.74K derived: sum of 3 quarters · filed 2019-08-12 | $266.66K derived: sum of 4 quarters · filed 2019-08-12 |
| 2018-03-31 | $71.05K 10-Q · filed 2019-05-13 | $122.80K derived: sum of 2 quarters · filed 2019-05-13 | $169.72K derived: sum of 3 quarters · filed 2019-05-13 | |
| 2017-12-31 | $51.75K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-22 | $98.67K derived: sum of 2 quarters · filed 2019-03-22 | $199.78K 10-K · filed 2019-03-22 | |
| 2017-09-30 | $46.92K 10-Q · filed 2018-11-13 | $148.03K 10-Q · filed 2018-11-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |